Efficacy and Safety of Curcumin and Curcuma longa Extract in the Treatment of Arthritis: A Systematic Review and Meta-Analysis of Randomized Controlled Trial
- PMID: 35935936
- PMCID: PMC9353077
- DOI: 10.3389/fimmu.2022.891822
Efficacy and Safety of Curcumin and Curcuma longa Extract in the Treatment of Arthritis: A Systematic Review and Meta-Analysis of Randomized Controlled Trial
Abstract
Background: Modern pharmacological research found that the chemical components of Curcuma longa L. are mainly curcumin and turmeric volatile oil. Several recent randomized controlled trials (RCT) have shown that curcumin improves symptoms and inflammation in patients with arthritis.
Methods: Pubmed, Cochran Library, CNKI, and other databases were searched to collect the randomized controlled trials (RCTs). Then, the risk of bias of RCTs were assessed and data of RCTs were extracted. Finally, RevMan 5.3 was utilized for meta-analysis.
Results: Twenty-nine (29) RCTs involving 2396 participants and 5 types of arthritis were included. The arthritis included Ankylosing Spondylitis (AS), Rheumatoid Arthritis (RA), Osteoarthritis (OA), Juvenile idiopathic arthritis (JIA) and gout/hyperuricemia. Curcumin and Curcuma longa Extract were administered in doses ranging from 120 mg to 1500 mg for a duration of 4-36 weeks. In general, Curcumin and Curcuma longa Extract showed safety in all studies and improved the severity of inflammation and pain levels in these arthritis patients. However, more RCTs are needed in the future to elucidate the effect of Curcumin and Curcuma longa Extract supplementation in patients with arthritis, including RA, OA, AS and JIA.
Conclusion: Curcumin and Curcuma longa Extract may improve symptoms and inflammation levels in people with arthritis. However, due to the low quality and small quantity of RCTs, the conclusions need to be interpreted carefully.
Keywords: Curcuma longa extract; ankylosing spondylitis; curcumin; juvenile idiopathic arthritis; meta-analysis; osteoarthritis; rheumatoid arthritis; systematic review.
Copyright © 2022 Zeng, Yang, Yang, Yu, Li, Xiang and Chen.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures














Similar articles
-
Curcumin and Curcuma longa Extract in the Treatment of 10 Types of Autoimmune Diseases: A Systematic Review and Meta-Analysis of 31 Randomized Controlled Trials.Front Immunol. 2022 Aug 1;13:896476. doi: 10.3389/fimmu.2022.896476. eCollection 2022. Front Immunol. 2022. PMID: 35979355 Free PMC article.
-
The efficacy and safety of Curcuma longa extract and curcumin supplements on osteoarthritis: a systematic review and meta-analysis.Biosci Rep. 2021 Jun 25;41(6):BSR20210817. doi: 10.1042/BSR20210817. Biosci Rep. 2021. PMID: 34017975 Free PMC article.
-
Safety and efficacy of probiotic supplementation in 8 types of inflammatory arthritis: A systematic review and meta-analysis of 34 randomized controlled trials.Front Immunol. 2022 Sep 23;13:961325. doi: 10.3389/fimmu.2022.961325. eCollection 2022. Front Immunol. 2022. PMID: 36217542 Free PMC article.
-
Efficacy and safety of dietary polyphenols in rheumatoid arthritis: A systematic review and meta-analysis of 47 randomized controlled trials.Front Immunol. 2023 Mar 22;14:1024120. doi: 10.3389/fimmu.2023.1024120. eCollection 2023. Front Immunol. 2023. PMID: 37033930 Free PMC article.
-
Safety and Efficacy of Turmeric (Curcuma longa) Extract and Curcumin Supplements in Musculoskeletal Health: A Systematic Review and Meta-Analysis.Altern Ther Health Med. 2023 Sep;29(6):12-24. Altern Ther Health Med. 2023. PMID: 37574203
Cited by
-
Phytonutrients in the promotion of healthspan: a new perspective.Front Nutr. 2024 Jul 12;11:1409339. doi: 10.3389/fnut.2024.1409339. eCollection 2024. Front Nutr. 2024. PMID: 39070259 Free PMC article. Review.
-
Research progress on nanotechnology of traditional Chinese medicine to enhance the therapeutic effect of osteoarthritis.Drug Deliv Transl Res. 2024 Jun;14(6):1517-1534. doi: 10.1007/s13346-024-01517-w. Epub 2024 Jan 15. Drug Deliv Transl Res. 2024. PMID: 38225521 Review.
-
Premature ovarian insufficiency: a review on the role of oxidative stress and the application of antioxidants.Front Endocrinol (Lausanne). 2023 Aug 1;14:1172481. doi: 10.3389/fendo.2023.1172481. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37600717 Free PMC article. Review.
-
In silico identification of compounds from Piper sarmentosum Roxb leaf fractionated extract inhibit interleukin-6 to prevent rheumatoid arthritis.Front Pharmacol. 2024 Mar 21;15:1358037. doi: 10.3389/fphar.2024.1358037. eCollection 2024. Front Pharmacol. 2024. PMID: 38576490 Free PMC article.
-
How Does Radiation Affect Curcumin Raw Material?Int J Mol Sci. 2024 Feb 21;25(5):2524. doi: 10.3390/ijms25052524. Int J Mol Sci. 2024. PMID: 38473770 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials